CHMP positive for Kevzara (sarilumab) to treat polymyalgia rheumatica – Sanofi
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Kevzara…. read more.